A critical breakthrough in cancer research is emerging with the use of mini-antibodies to re-engage dysfunctional p53. This essential malignant protector protein is frequently inactivated in many types of cancer, https://keybookmarks.com/story21966842/mini-antibodies-reactivate-tumor-suppressor-p53-the-new-approach-for-tumor-management